Flygare Johan, Aspesi Anna, Bailey Joshua C, Miyake Koichi, Caffrey Jacqueline M, Karlsson Stefan, Ellis Steven R
Department of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University Hospital, Sweden.
Blood. 2007 Feb 1;109(3):980-6. doi: 10.1182/blood-2006-07-038232. Epub 2006 Sep 21.
Diamond-Blackfan anemia (DBA) typically presents with red blood cell aplasia that usually manifests in the first year of life. The only gene currently known to be mutated in DBA encodes ribosomal protein S19 (RPS19). Previous studies have shown that the yeast RPS19 protein is required for a specific step in the maturation of 40S ribosomal subunits. Our objective here was to determine whether the human RPS19 protein functions at a similar step in 40S subunit maturation. Studies where RPS19 expression is reduced by siRNA in the hematopoietic cell line, TF-1, show that human RPS19 is also required for a specific step in the maturation of 40S ribosomal subunits. This maturation defect can be monitored by studying rRNA-processing intermediates along the ribosome synthesis pathway. Analysis of these intermediates in CD34- cells from the bone marrow of patients with DBA harboring mutations in RPS19 revealed a pre-rRNA-processing defect similar to that observed in TF-1 cells where RPS19 expression was reduced. This defect was observed to a lesser extent in CD34+ cells from patients with DBA who have mutations in RPS19.
先天性纯红细胞再生障碍性贫血(DBA)通常表现为红细胞再生障碍,这通常在生命的第一年出现。目前已知在DBA中发生突变的唯一基因编码核糖体蛋白S19(RPS19)。先前的研究表明,酵母RPS19蛋白是40S核糖体亚基成熟过程中特定步骤所必需的。我们这里的目的是确定人类RPS19蛋白在40S亚基成熟的类似步骤中是否发挥作用。在造血细胞系TF-1中通过siRNA降低RPS19表达的研究表明,人类RPS19也是40S核糖体亚基成熟过程中特定步骤所必需的。这种成熟缺陷可以通过研究核糖体合成途径中的rRNA加工中间体来监测。对来自RPS19发生突变的DBA患者骨髓中的CD34-细胞中的这些中间体进行分析,发现了与在RPS19表达降低的TF-1细胞中观察到的类似的前体rRNA加工缺陷。在RPS19发生突变的DBA患者的CD34+细胞中也观察到了程度较轻的这种缺陷。